HIV/HCV Coinfection in Taiwan

Area of Science:

• Epidemiology
• Public Health
• Infectious Diseases

Background:

• Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) coinfection presents a significant global health challenge.
• Injection drug users (IDUs) are a key demographic for HIV/HCV transmission in Taiwan.
• Taiwan's HIV epidemic, driven by IDUs since 2005, saw a rise in coinfection rates.

Purpose of the Study:

• To review the current literature on HIV/HCV coinfection in Taiwan.
• To understand the epidemiology and risk factors associated with HIV/HCV coinfection.
• To inform the management strategies for coinfection in Taiwan.

Main Methods:

• A narrative review of existing literature was conducted.
• Searches were performed in PubMed, Ovid MEDLINE, and Cochrane Library databases up to August 2015.
• Studies focusing on the epidemiology and risk factors of HIV/HCV coinfection in Taiwan were analyzed.

Main Results:

• The implementation of a harm-reduction program in 2006 by Taiwan CDC led to a decline in the HIV epidemic.
• A subsequent decrease was observed in the proportion of cases attributed to IDUs.
• The prevalence of HIV/HCV coinfection also showed a downward trend following the program's launch.

Conclusions:

• Harm-reduction strategies have been effective in mitigating the HIV epidemic and associated coinfections in Taiwan.
• Continued monitoring and tailored management approaches are crucial for addressing HIV/HCV coinfection.
• Understanding regional epidemiology is vital for public health interventions.